#BEGIN_DRUGCARD DB03297

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H8O2S

# Chemical_IUPAC_Name:
(R)-phenylmethanesulfinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Benzylsulfinic Acid

# HET_ID:
PMS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H8O2S/c8-10(9)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,8,9)

# InChI_Key:
InChIKey=NVSONFIVLCXXDH-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3297

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
156.202

# Molecular_Weight_Mono:
156.02450019

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1WPR

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.64

# Predicted_LogS:
-1.3

# Predicted_Water_Solubility:
8.47e+00 g/l

# Primary_Accession_No:
DB03297

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3311411

# PubChem_Substance_ID:
46507289

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02622

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[S@@](=O)CC1=CC=CC=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:07 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Membrane

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
HPN

# Drug_Target_1_GenBank_ID_Gene:
M18930

# Drug_Target_1_GenBank_ID_Protein:
306886

# Drug_Target_1_GeneCard_ID:
HPN

# Drug_Target_1_Gene_Name:
HPN

# Drug_Target_1_Gene_Sequence:
>1254 bp
ATGGCGCAGAAGGAGGGTGGCCGGACTGTGCCATGCTGCTCCAGACCCAAGGTGGCAGCT
CTCACTGCGGGGACCCTGCTACTTCTGACAGCCATCGGGGCGGCATCCTGGGCCATTGTG
GCTGTTCTCCTCAGGAGTGACCAGGAGCCGCTGTACCCAGTGCAGGTCAGCTCTGCGGAC
GCTCGGCTCATGGTCTTTGACAAGACGGAAGGGACGTGGCGGCTGCTGTGCTCCTCGCGC
TCCAACGCCAGGGTAGCCGGACTCAGCTGCGAGGAGATGGGCTTCCTCAGGGCACTGACC
CACTCCGAGCTGGACGTGCGAACGGCGGGCGCCAATGGCACGTCGGGCTTCTTCTGTGTG
GACGAGGGGAGGCTGCCCCACACCCAGAGGCTGCTGGAGGTCATCTCCGTGTGTGATTGC
CCCAGAGGCCGTTTCTTGGCCGCCATCTGCCAAGACTGTGGCCGCAGGAAGCTGCCCGTG
GACCGCATCGTGGGAGGCCGGGACACCAGCTTGGGCCGGTGGCCGTGGCAAGTCAGCCTT
CGCTATGATGGAGCACACCTCTGTGGGGGATCCCTGCTCTCCGGGGACTGGGTGCTGACA
GCCGCCCACTGCTTCCCGGAGCGGAACCGGGTCCTGTCCCGATGGCGAGTGTTTGCCGGT
GCCGTGGCCCAGGCCTCTCCCCACGGTCTGCAGCTGGGGGTGCAGGCTGTGGTCTACCAC
GGGGGCTATCTTCCCTTTCGGGACCCCAACAGCGAGGAGAACAGCAACGATATTGCCCTG
GTCCACCTCTCCAGTCCCCTGCCCCTCACAGAATACATCCAGCCTGTGTGCCTCCCAGCT
GCCGGCCAGGCCCTGGTGGATGGCAAGATCTGTACCGTGACGGGCTGGGGCAACACGCAG
TACTATGGCCAACAGGCCGGGGTACTCCAGGAGGCTCGAGTCCCCATAATCAGCAATGAT
GTCTGCAATGGCGCTGACTTCTATGGAAACCAGATCAAGCCCAAGATGTTCTGTGCTGGC
TACCCCGAGGGTGGCATTGATGCCTGCCAGGGCGACAGCGGTGGTCCCTTTGTGTGTGAG
GACAGCATCTCTCGGACGCCACGTTGGCGGCTGTGTGGCATTGTGAGTTGGGGCACTGGC
TGTGCCCTGGCCCAGAAGCCAGGCGTCTACACCAAAGTCAGTGACTTCCGGGAGTGGATC
TTCCAGGCCATAAAGACTCACTCCGAAGCCAGCGGCATGGTGACCCAGCTCTGA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
1885621	Tsuji A, Torres-Rosado A, Arai T, Le Beau MM, Lemons RS, Chou SH, Kurachi K: Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem. 1991 Sep 5;266(25):16948-53.
2835076	Leytus SP, Loeb KR, Hagen FS, Kurachi K, Davie EW: A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry. 1988 Feb 9;27(3):1067-74.
8346233	Torres-Rosado A, O'Shea KS, Tsuji A, Chou SH, Kurachi K: Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7181-5.

# Drug_Target_1_HGNC_ID:
HGNC:5155

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3851

# Drug_Target_1_Locus:
19q11-q13.2

# Drug_Target_1_Molecular_Weight:
45012

# Drug_Target_1_Name:
Serine protease hepsin

# Drug_Target_1_Number_of_Residues:
417

# Drug_Target_1_PDB_ID:
1Z8G

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00089	Trypsin
PF09272	Hepsin-SRCR

# Drug_Target_1_Protein_Sequence:
>Serine protease hepsin
MAQKEGGRTVPCCSRPKVAALTAGTLLLLTAIGAASWAIVAVLLRSDQEPLYPVQVSSAD
ARLMVFDKTEGTWRLLCSSRSNARVAGLSCEEMGFLRALTHSELDVRTAGANGTSGFFCV
DEGRLPHTQRLLEVISVCDCPRGRFLAAICQDCGRRKLPVDRIVGGRDTSLGRWPWQVSL
RYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAVAQASPHGLQLGVQAVVYH
GGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQ
YYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCE
DSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIKTHSEASGMVTQL

# Drug_Target_1_Reaction:
Cleavage after basic amino-acid residues, with Arg strongly preferred to Lys

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Plays an essential role in cell growth and maintenance of cell morphology

# Drug_Target_1_SwissProt_ID:
P05981

# Drug_Target_1_SwissProt_Name:
HEPS_HUMAN

# Drug_Target_1_Synonyms:
EC 3.4.21.106
Transmembrane protease, serine 1

# Drug_Target_1_Theoretical_pI:
7.66

# Drug_Target_1_Transmembrane_Regions:
24-44

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AF521587

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
>1593 bp
ATGTTAAAGAAAGTATTAAGTTGTTGTATTGCAGCCACATTTGGTATTTATTCCGCATCA
AGTCTGGCTCAAAGTTCTGTTATAAATTCTACTGAAAACTCACAACAACCTATTGCTCCA
CTGGTGTTGGCTTCATCAGATGATGCGATCACTGATCGCTATATTGTTGTATTGAAACAA
CCGCAGATGCTAATGAATGACGCGGCTGGATTACAGCAGTTCACTCAACAAACGGTAGGC
CTCATGGCCAATTCGTTTTCAATCAAAACAGACGATGTTTTTGATAGTTCCATTATTGGC
TTTGTGGCAAATCTAGACGCACTTCAATTAAAGCAACTCAGACGTGATTCTCGGGTGGAA
TACATTGAACAAGACCAAATACTCAGTATCGATCCTGTTGTTTCAAATGAAGCCGTTCAA
AGCAACGCGATTTGGGGGCTAGACCGAATAGATCAGAGAAACCTTCCTTTGGATCGAAAC
TATAATGCTAACTTTGATGGCTTTGGCGTCACAGCATACGTGATTGATACGGGAGTTAAT
AACAACCATGAGGAATTCGGCGGGCGCTCGGTTTCTGGCTATGATTTCGTAGATAATGAT
GCTGATTCGAGTGACTGTAATGGGCATGGTACCCACGTTGCAGGAACGATTGGCGGCAGC
CAGTATGGTGTGGCTAAAAACGTTAACATTGTTGGGGTAAGAGTACTTAGCTGTTCGGGT
TCAGGAACCACATCCGGCGTGATTTCTGGTGTGGATTGGGTAGCACAAAATGCATCAGGG
CCTTCGGTCGCCAACATGAGTTTAGGTGGAGGTCAATCCACTGCATTAGATAGCGCGGTG
CAAGGCGCGATTCAATCTGGAGTGAGTTTTATGTTGGCGGCAGGTAACTCAAATGCCGAT
GCGTGTAATACATCACCAGCTCGTGTACCAAGTGGTGTGACGGTAGGCTCAACGACCAGC
TCTGATTCGCGTTCAAGTTTCTCGAACTGGGGCAGTTGTGTTGACCTATTCGCACCTGGG
TCTCAAATTAAGTCAGCTTGGTATGATGGCGGCTATAAAACGATTAGCGGAACCTCCATG
GCGACGCCACATGTTGCCGGCGTTGCAGCCTTGTACTTACAAGAAAACAACGGCTTAACT
CCGCTTCAGCTTACAGGGTTACTGAACTCAAGAGCCTCGGAGAATAAGGTTTCTGACACA
AGAGGCACCACCAATAAACTGCTATATAGCTTGGCAGACAGTGGTTGTGAGCCGGATTGC
GGTGGTCCAACACCTGGACCGGATCCAGATGGAAAGCTAGTCTCTGGCGTGCCGGTTAAT
GGATTAAGTGGCAGCCGAGGACAAAAGGATTACTTCTACATGGACTTACAACAGGGCCAG
CAGCTAACAGTGGTCACCATTGGTGGCACAGGCGACGCGGATCTGTATCTACGTTTTGGA
GACAAACCAACGCTCAATACTTGGGACTGTCGACCTTATCGTTCGGGTAACAGTGAGACT
TGTACGGTGAATGTCACCCAAAGCGGCAGATATCATGTGATGTTGAACGCTTACTCGGCT
TACAGTGGCTTGACGCTCCAAGCAAACTTTTAA

# Drug_Target_2_General_Function:
Involved in peptidase activity

# Drug_Target_2_General_References:
12423352	Arnorsdottir J, Smaradottir RB, Magnusson OT, Thorbjarnardottir SH, Eggertsson G, Kristjansson MM: Characterization of a cloned subtilisin-like serine proteinase from a psychrotrophic Vibrio species. Eur J Biochem. 2002 Nov;269(22):5536-46.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5211

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
55683

# Drug_Target_2_Name:
Extracellular subtilisin-like serine proteinase

# Drug_Target_2_Number_of_Residues:
530

# Drug_Target_2_PDB_ID:
1SH7

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00082	Peptidase_S8
PF04151	PPC
PF05922	Subtilisin_N

# Drug_Target_2_Protein_Sequence:
>Extracellular subtilisin-like serine proteinase
MLKKVLSCCIAATFGIYSASSLAQSSVINSTENSQQPIAPLVLASSDDAITDRYIVVLKQ
PQMLMNDAAGLQQFTQQTVGLMANSFSIKTDDVFDSSIIGFVANLDALQLKQLRRDSRVE
YIEQDQILSIDPVVSNEAVQSNAIWGLDRIDQRNLPLDRNYNANFDGFGVTAYVIDTGVN
NNHEEFGGRSVSGYDFVDNDADSSDCNGHGTHVAGTIGGSQYGVAKNVNIVGVRVLSCSG
SGTTSGVISGVDWVAQNASGPSVANMSLGGGQSTALDSAVQGAIQSGVSFMLAAGNSNAD
ACNTSPARVPSGVTVGSTTSSDSRSSFSNWGSCVDLFAPGSQIKSAWYDGGYKTISGTSM
ATPHVAGVAALYLQENNGLTPLQLTGLLNSRASENKVSDTRGTTNKLLYSLADSGCEPDC
GGPTPGPDPDGKLVSGVPVNGLSGSRGQKDYFYMDLQQGQQLTVVTIGGTGDADLYLRFG
DKPTLNTWDCRPYRSGNSETCTVNVTQSGRYHVMLNAYSAYSGLTLQANF

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q8GB52

# Drug_Target_2_SwissProt_Name:
Q8GB52_9VIBR

# Drug_Target_2_Synonyms:
EC 3.4.21.-

# Drug_Target_2_Theoretical_pI:
4.43

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
S79600

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
estB

# Drug_Target_3_Gene_Sequence:
>657 bp
ATGACCGAACCCTTGATTCTTCAGCCCGCCAAGCCGGCAGACGCCTGCGTAATCTGGTTG
CATGGCCTGGGTGCCGATCGCTACGACTTTATGCCGGTAGCCGAAGCCCTGCAGGAAAGC
CTGCTGACCACGCGCTTCGTCTTGCCCCAGGCGCCGACACGCCCGGTGACCATCAACGGC
GGCTACGAGATGCCGAGCTGGTACGACATCAAGGCCATGAGCCCGGCCCGTTCGATCAGC
CTGGAGGAGCTGGAAGTGTCGGCCAAAATGGTCACGGATCTGATCGAAGCGCAGAAGAGA
ACCGGAATAGACGCCTCTCGGATTTTCCTCGCCGGTTTTTCCCAGGGTGGCGCCGTGGTT
TTCCACACGGCGTTTATAAATTGGCAAGGGCCCTTGGGCGGCGTCATTGCCCTCTCCACC
TACGCGCCGACTTTCGGCGACGAGCTGGAATTGTCTGCCAGCCAGCAACGCATTCCCGCC
CTGTGCCTGCATGGCCAGTACGACGACGTGGTGCAGAACGCCATGGGCCGCAGCGCTTTT
GAGCATTTGAAGAGCCGTGGTGTCACCGTGACATGGCAGGAATACCCAATGGGCCACGAA
GTGTTACCTCAAGAGATACACGACATCGGTGCCTGGCTGGCCGCTCGCCTGGGCTGA

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
1368750	Hong KH, Jang WH, Choi KD, Yoo OJ: Characterization of Pseudomonas fluorescens carboxylesterase: cloning and expression of the esterase gene in Escherichia coli. Agric Biol Chem. 1991 Nov;55(11):2839-45.
9438866	Kim KK, Song HK, Shin DH, Hwang KY, Choe S, Yoo OJ, Suh SW: Crystal structure of carboxylesterase from Pseudomonas fluorescens, an alpha/beta hydrolase with broad substrate specificity. Structure. 1997 Dec 15;5(12):1571-84.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
5212

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
23881

# Drug_Target_3_Name:
Carboxylesterase 2

# Drug_Target_3_Number_of_Residues:
218

# Drug_Target_3_PDB_ID:
1AUR

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02230	Abhydrolase_2

# Drug_Target_3_Protein_Sequence:
>Carboxylesterase 2
MTEPLILQPAKPADACVIWLHGLGADRYDFMPVAEALQESLLTTRFVLPQAPTRPVTING
GYEMPSWYDIKAMSPARSISLEELEVSAKMVTDLIEAQKRTGIDASRIFLAGFSQGGAVV
FHTAFINWQGPLGGVIALSTYAPTFGDELELSASQQRIPALCLHGQYDDVVQNAMGRSAF
EHLKSRGVTVTWQEYPMGHEVLPQEIHDIGAWLAARLG

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Hydrolyzes carboxylic ester bonds with relatively broad substrate specificity

# Drug_Target_3_SwissProt_ID:
Q53547

# Drug_Target_3_SwissProt_Name:
EST2_PSEFL

# Drug_Target_3_Synonyms:
EC 3.1.1.1
Esterase II

# Drug_Target_3_Theoretical_pI:
4.86

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
Z94043

# Drug_Target_4_GenBank_ID_Protein:
1945717

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
rsbQ

# Drug_Target_4_Gene_Sequence:
>810 bp
TCACACGTGTGCTTTTAAATAATCGCCGATCAGCTGTATCGTCTCATCTGGATGGCTCAT
ATGAGGGCAATGTCCGCGAGCCTCCATTTGTTTCAGACTGCTATAAGGCAGATGCTGATG
CATATACTTACCTACTGTTGCAGGTGCGATGATATCATCTGCACATTGGAGAATAAGAGA
GGGAACCGTTACCTTCGAAAGATCCTCTCGGTGATCAGAAAAAAACGCCGCTTTCGCGAA
TTGGCGGGCAATGACAGGATCAGTAGAACAAAAACGGCTTTCAAGCTCTTCCTTAATTTC
AGGCCGATCTGGCTGATTCAGAACGGTTGCCGCAAATACAGTCGCCCAGCCGATATAATT
TTTCTCCATCATCTCCAGCAAGCCAAGGAGCTGCTCCTCTTCAAATCCTCCGTAATACTC
AGGCGGATCATTCAAATAGCAAGGAGAAGGCCCCACCATCACCAGATGGGAAAAAAGCTC
CGGGCGGCGGATGGATGCAAGCATCCCAATCAAGGCCCCGACGGAGTGACCCACAAACAC
GGTTTCCTTCAGATCTAAAGCTTCACAAACATCAAGAACATCCTGGGCATAGCCGTCAAG
TGTCTGGTAACGATTCAGGTCATATGCGCGCAAATCTGAATGTCCCGAACCGACGTAATC
AAATAAAATCACCCGATGATCTTCTTCAAAGGCAGGTGCCACGGCATTCCACACGCTTTG
ATCGCATCCAAAACCAGGTGCGAACATGATAGATGCTTTGCCGCTGCCTTTCACCTTCAC
ATGATTTCTAGACAAAATCGCTTCGTTCAT

# Drug_Target_4_General_Function:
Involved in hydrolase activity

# Drug_Target_4_General_References:
10632888	Vijay K, Brody MS, Fredlund E, Price CW: A PP2C phosphatase containing a PAS domain is required to convey signals of energy stress to the sigmaB transcription factor of Bacillus subtilis. Mol Microbiol. 2000 Jan;35(1):180-8.
11591687	Brody MS, Vijay K, Price CW: Catalytic function of an alpha/beta hydrolase is required for energy stress activation of the sigma(B) transcription factor in Bacillus subtilis. J Bacteriol. 2001 Nov;183(21):6422-8.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
3490

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
30020

# Drug_Target_4_Name:
Sigma factor sigB regulation protein rsbQ

# Drug_Target_4_Number_of_Residues:
269

# Drug_Target_4_PDB_ID:
1WPR

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00561	Abhydrolase_1

# Drug_Target_4_Protein_Sequence:
>Sigma factor sigB regulation protein rsbQ
MNEAILSRNHVKVKGSGKASIMFAPGFGCDQSVWNAVAPAFEEDHRVILFDYVGSGHSDL
RAYDLNRYQTLDGYAQDVLDVCEALDLKETVFVGHSVGALIGMLASIRRPELFSHLVMVG
PSPCYLNDPPEYYGGFEEEQLLGLLEMMEKNYIGWATVFAATVLNQPDRPEIKEELESRF
CSTDPVIARQFAKAAFFSDHREDLSKVTVPSLILQCADDIIAPATVGKYMHQHLPYSSLK
QMEARGHCPHMSHPDETIQLIGDYLKAHV

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Positive regulator required for energy stress activation of the sigma-B transcription factor. Could be required for rsbP phosphatase activity

# Drug_Target_4_SwissProt_ID:
O07015

# Drug_Target_4_SwissProt_Name:
RSBQ_BACSU

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
5.01

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
SOD2

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6963

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Superoxide dismutase [Mn], mitochondrial

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
P04179

# Drug_Target_5_SwissProt_Name:
SODM_HUMAN

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Secreted protein. Cytoplasmic granule. Note=Mast cell granules

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
CMA1

# Drug_Target_6_GenBank_ID_Gene:
M64269

# Drug_Target_6_GenBank_ID_Protein:
180542

# Drug_Target_6_GeneCard_ID:
CMA1

# Drug_Target_6_Gene_Name:
CMA1

# Drug_Target_6_Gene_Sequence:
>744 bp
ATGCTGCTTCTTCCTCTCCCCCTGCTGCTCTTTCTCTTGTGCTCCAGAGCTGAAGCTGGG
GAGATCATCGGGGGCACAGAATGCAAGCCACATTCCCGCCCCTACATGGCCTACCTGGAA
ATTGTAACTTCCAACGGTCCCTCAAAATTTTGTGGTGGTTTCCTTATAAGACGGAACTTT
GTGCTGACGGCTGCTCATTGTGCAGGAAGGTCTATAACAGTCACCCTTGGAGCCCATAAC
ATAACAGAGGAAGAAGACACATGGCAGAAGCTTGAGGTTATAAAGCAATTCCGTCATCCA
AAATATAACACTTCTACTCTTCACCACGATATCATGTTACTAAAGTTGAAGGAGAAAGCC
AGCCTGACCCTGGCTGTGGGGACACTCCCCTTCCCATCACAATTCAACTTTGTCCCACCT
GGGAGAATGTGCCGGGTGGCTGGCTGGGGAAGAACAGGTGTGTTGAAGCCGGGCTCAGAC
ACTCTGCAAGAGGTGAAGCTGAGACTCATGGATCCCCAGGCCTGCAGCCACTTCAGAGAC
TTTGACCACAATCTTCAGCTGTGTGTGGGCAATCCCAGGAAGACAAAATCTGCATTTAAG
GGAGACTCTGGGGGCCCTCTTCTGTGTGCTGGGGTGGCCCAGGGCATCGTATCCTATGGA
CGGTCGGATGCAAAGCCCCCTGCTGTCTTCACCCGAATCTCCCATTACCGGCCCTGGATC
AACCAGATCCTGCAGGCAAATTAA

# Drug_Target_6_General_Function:
Involved in protease activity

# Drug_Target_6_General_References:
1894611	Urata H, Kinoshita A, Perez DM, Misono KS, Bumpus FM, Graham RM, Husain A: Cloning of the gene and cDNA for human heart chymase. J Biol Chem. 1991 Sep 15;266(26):17173-9.
2049082	Jenne DE, Tschopp J: Angiotensin II-forming heart chymase is a mast-cell-specific enzyme. Biochem J. 1991 Jun 1;276 ( Pt 2):567-8.
2071582	Caughey GH, Zerweck EH, Vanderslice P: Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem. 1991 Jul 15;266(20):12956-63.
8495723	Sukenaga Y, Kido H, Neki A, Enomoto M, Ishida K, Takagi K, Katunuma N: Purification and molecular cloning of chymase from human tonsils. FEBS Lett. 1993 May 24;323(1-2):119-22.
9400368	McGrath ME, Mirzadegan T, Schmidt BF: Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A. Biochemistry. 1997 Nov 25;36(47):14318-24.
9931257	Pereira PJ, Wang ZM, Rubin H, Huber R, Bode W, Schechter NM, Strobl S: The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J Mol Biol. 1999 Feb 12;286(1):163-73.

# Drug_Target_6_HGNC_ID:
HGNC:2097

# Drug_Target_6_HPRD_ID:
00346

# Drug_Target_6_ID:
1615

# Drug_Target_6_Locus:
14q11.2

# Drug_Target_6_Molecular_Weight:
27325

# Drug_Target_6_Name:
Chymase

# Drug_Target_6_Number_of_Residues:
247

# Drug_Target_6_PDB_ID:
1NN6

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00089	Trypsin

# Drug_Target_6_Protein_Sequence:
>Chymase precursor
MLLLPLPLLLFLLCSRAEAGEIIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNF
VLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKA
SLTLAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRD
FDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQGIVSYGRSDAKPPAVFTRISHYRPWI
NQILQAN

# Drug_Target_6_Reaction:
Preferential cleavage: Phe! > Tyr! > Trp! > Leu!

# Drug_Target_6_Signals:
1-19

# Drug_Target_6_Specific_Function:
Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion

# Drug_Target_6_SwissProt_ID:
P23946

# Drug_Target_6_SwissProt_Name:
CMA1_HUMAN

# Drug_Target_6_Synonyms:
Chymase precursor
EC 3.4.21.39
Mast cell protease I

# Drug_Target_6_Theoretical_pI:
9.71

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Secreted protein

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
K02496

# Drug_Target_7_GenBank_ID_Protein:
142526

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
apr

# Drug_Target_7_Gene_Sequence:
>1149 bp
GTGAGAGGCAAAAAAGTATGGATCAGTTTGCTGTTTGCTTTAGCGTTAATCTTTACGATG
GCGTTCGGCAGCACATCCTCTGCCCAGGCGGCAGGGAAATCAAACGGGGAAAAGAAATAT
ATTGTCGGGTTTAAACAGACAATGAGCACGATGAGCGCCGCTAAGAAGAAAGATGTCATT
TCTGAAAAAGGCGGGAAAGTGCAAAAGCAATTCAAATATGTAGACGCAGCTTCAGCTACA
TTAAACGAAAAAGCTGTAAAAGAATTGAAAAAAGACCCGAGCGTCGCTTACGTTGAAGAA
GATCACGTAGCACATGCGTACGCGCAGTCCGTGCCTTACGGCGTATCACAAATTAAAGCC
CCTGCTCTGCACTCTCAAGGCTACACTGGATCAAATGTTAAAGTAGCGGTTATCGACAGC
GGTATCGATTCTTCTCATCCTGATTTAAAGGTAGCAGGCGGAGCCAGCATGGTTCCTTCT
GAAACAAATCCTTTCCAAGACAACAACTCTCACGGAACTCACGTTGCCGGCACAGTTGCG
GCTCTTAATAACTCAATCGGTGTATTAGGCGTTGCGCCAAGCGCATCACTTTACGCTGTA
AAAGTTCTCGGTGCTGACGGTTCCGGCCAATACAGCTGGATCATTAACGGAATCGAGTGG
GCGATCGCAAACAATATGGACGTTATTAACATGAGCCTCGGCGGACCTTCTGGTTCTGCT
GCTTTAAAAGCGGCAGTTGATAAAGCCGTTGCATCCGGCGTCGTAGTCGTTGCGGCAGCC
GGTAACGAAGGCACTTCCGGCAGCTCAAGCACAGTGGGCTACCCTGGTAAATACCCTTCT
GTCATTGCAGTAGGCGCTGTTGACAGCAGCAACCAAAGAGCATCTTTCTCAAGCGTAGGA
CCTGAGCTTGATGTCATGGCACCTGGCGTATCTATCCAAAGCACGCTTCCTGGAAACAAA
TACGGGGCGTACAACGGTACGTCAATGGCATCTCCGCACGTTGCCGGAGCGGCTGCTTTG
ATTCTTTCTAAGCACCCGAACTGGACAAACACTCAAGTCCGCAGCAGTTTAGAAAACACC
ACTACAAAACTTGGTGATTCTTTCTACTATGGAAAAGGGCTGATCAACGTACAGGCGGCA
GCTCAGTAA

# Drug_Target_7_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_7_General_References:
12524032	Peng Y, Huang Q, Zhang RH, Zhang YZ: Purification and characterization of a fibrinolytic enzyme produced by Bacillus amyloliquefaciens DC-4 screened from douchi, a traditional Chinese soybean food. Comp Biochem Physiol B Biochem Mol Biol. 2003 Jan;134(1):45-52.
2684274	Pantoliano MW, Whitlow M, Wood JF, Dodd SW, Hardman KD, Rollence ML, Bryan PN: Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding. Biochemistry. 1989 Sep 5;28(18):7205-13.
4399039	Alden RA, Wright CS, Kraut J: A hydrogen-bond network at the active site of subtilisin BPN'. Philos Trans R Soc Lond B Biol Sci. 1970 Feb 12;257(813):119-24.
5249818	Markland FS, Shaw E, Smith EL: Identification of histidine 64 in the active site of subtilisin. Proc Natl Acad Sci U S A. 1968 Dec;61(4):1440-7.
6065094	Markland FS, Smith EL: Subtilisin BPN. VII. Isolation of cyanogen bromide peptides and the complete amino acid sequence. J Biol Chem. 1967 Nov 25;242(22):5198-211.
6090391	Vasantha N, Thompson LD, Rhodes C, Banner C, Nagle J, Filpula D: Genes for alkaline protease and neutral protease from Bacillus amyloliquefaciens contain a large open reading frame between the regions coding for signal sequence and mature protein. J Bacteriol. 1984 Sep;159(3):811-9.
6316278	Wells JA, Ferrari E, Henner DJ, Estell DA, Chen EY: Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res. 1983 Nov 25;11(22):7911-25.
6387152	Hirono S, Akagawa H, Mitsui Y, Iitaka Y: Crystal structure at 2.6 A resolution of the complex of subtilisin BPN' with streptomyces subtilisin inhibitor. J Mol Biol. 1984 Sep 15;178(2):389-414.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
2517

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
39181

# Drug_Target_7_Name:
Subtilisin BPN'

# Drug_Target_7_Number_of_Residues:
382

# Drug_Target_7_PDB_ID:
1SUP

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00082	Peptidase_S8
PF05922	Subtilisin_N

# Drug_Target_7_Protein_Sequence:
>Subtilisin BPN' precursor
MRGKKVWISLLFALALIFTMAFGSTSSAQAAGKSNGEKKYIVGFKQTMSTMSAAKKKDVI
SEKGGKVQKQFKYVDAASATLNEKAVKELKKDPSVAYVEEDHVAHAYAQSVPYGVSQIKA
PALHSQGYTGSNVKVAVIDSGIDSSHPDLKVAGGASMVPSETNPFQDNNSHGTHVAGTVA
ALNNSIGVLGVAPSASLYAVKVLGADGSGQYSWIINGIEWAIANNMDVINMSLGGPSGSA
ALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAVDSSNQRASFSSVG
PELDVMAPGVSIQSTLPGNKYGAYNGTSMASPHVAGAAALILSKHPNWTNTQVRSSLENT
TTKLGDSFYYGKGLINVQAAAQ

# Drug_Target_7_Reaction:
Hydrolysis of proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. Hydrolyses peptide amides

# Drug_Target_7_Signals:
1-32

# Drug_Target_7_Specific_Function:
Subtilisin is an extracellular alkaline serine protease, it catalyzes the hydrolysis of proteins and peptide amides. Has a high substrate specificity to fibrin

# Drug_Target_7_SwissProt_ID:
P00782

# Drug_Target_7_SwissProt_Name:
SUBT_BACAM

# Drug_Target_7_Synonyms:
Alkaline protease
EC 3.4.21.62
Subtilisin BPN' precursor
Subtilisin DFE
Subtilisin Novo

# Drug_Target_7_Theoretical_pI:
9.61

# Drug_Target_7_Transmembrane_Regions:
None

#END_DRUGCARD DB03297
